Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

LACRISERT

HYDROXYPROPYL CELLULOSE

Standard Dose
5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Discontinued
Summary

Approval overview LACRISERT is listed in Drugs@FDA under application 018771 (NDA).

Review priority: N/A Marketing status: Discontinued Active ingredient HYDROXYPROPYL CELLULOSE Form and strength INSERT;OPHTHALMIC - 5MG Sponsor BAUSCH AND LOMB INC Submission history Latest submission status date: 2008-10-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview LACRISERT is listed in Drugs@FDA under application 018771 (NDA). Review priority: N/A Marketing status: Discontinued Active ingredient HYDROXYPROPYL CELLULOSE Form and strength INSERT;OPHTHALMIC - 5MG Sponsor BAUSCH AND LOMB INC Submission history Latest submission status date: 2008-10-30 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: N/A

Interaction Notes

  • No interaction notes stored yet.
LACRISERT (HYDROXYPROPYL CELLULOSE) | Drug Monograph | MedicHelpline